Takahiro Nishide

730 citations
11 papers · 615 indexed · h-index 9
Topics
Enzyme Production and Characterization (6 papers)Peptidase Inhibition and Analysis (2 papers)Pancreatitis Pathology and Treatment (2 papers)
Partner nations
Japan

In The Last Decade

Takahiro Nishide

10 papers receiving 597 citations

Peers

Takahiro Nishide
Comparison fields: 5 of 71
  • Molecular Biology 286
  • Biotechnology 218
  • Surgery 155
  • Oncology 138
  • Genetics 107
Replace Guangwu Guo with:
Guangwu Guo United States
Chihiro Yokoo Japan
Silvia Jordans Germany
Utpal K. Mukhopadhyay Canada
M. Järvinen Finland
Alan H. Deutch United States
M. Otte Germany
Stephen M. Manzella United States
Patrick Raber United States
Carlos Abel United States
Takahiro Nishide relative to Guangwu Guo United States Guangwu Guo's profile →
Citations per field
00.5×2.7×
Guangwu Guo · 1×
Citations per year

Countries citing papers authored by Takahiro Nishide

Since Specialization
Citations

This map shows the geographic impact of Takahiro Nishide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Nishide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Nishide more than expected).

Fields of papers citing papers by Takahiro Nishide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Nishide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Nishide. The network helps show where Takahiro Nishide may publish in the future.

Co-authorship network of co-authors of Takahiro Nishide

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Nishide. A scholar is included among the top collaborators of Takahiro Nishide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Nishide. Takahiro Nishide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 6
3 45
4
Expression of alpha-amylase in human lung cancers.
24
5 56
6 45
7 24
8 145
9 69
10 79
11 122

About Takahiro Nishide

Takahiro Nishide is a scholar working on Biotechnology, Pharmacy and Urology, having authored 11 papers that have together received 615 indexed citations. Recurring topics across this work include Enzyme Production and Characterization (6 papers), Peptidase Inhibition and Analysis (2 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Biotechnology (218 citations), Oncology (138 citations) and Hematology (56 citations). Takahiro Nishide has collaborated with scholars based in Japan. Frequent co-authors include Mitsuru Emi, Kenichi Matsubara, Michio Ogawa, Tatsuo Yamamoto, Kenichi Matsubara, Yusuke Nakamura, Michio Ogawa, Naohiro Tomita, Goro Kōsaki and Akira Horii. Their work appears in journals such as Biochemical and Biophysical Research Communications, Gene and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026